These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28005954)

  • 21. Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice.
    Martinez EC; Garg R; Shrivastava P; Gomis S; van Drunen Littel-van den Hurk S
    Antiviral Res; 2016 Nov; 135():108-119. PubMed ID: 27771388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LAIR-1 Limits Neutrophilic Airway Inflammation.
    Kumawat K; Geerdink RJ; Hennus MP; Roda MA; van Ark I; Leusink-Muis T; Folkerts G; van Oort-Jansen A; Mazharian A; Watson SP; Coenjaerts FE; Bont L; Meyaard L
    Front Immunol; 2019; 10():842. PubMed ID: 31080449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity.
    Claassen EA; van Bleek GM; Rychnavska ZS; de Groot RJ; Hensen EJ; Tijhaar EJ; van Eden W; van der Most RG
    Virology; 2007 Nov; 368(1):17-25. PubMed ID: 17632195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.
    Domachowske JB; Bonville CA; Gao JL; Murphy PM; Easton AJ; Rosenberg HF
    Cell Immunol; 2000 Nov; 206(1):1-6. PubMed ID: 11161432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blunted inflammatory and mucosal IgA responses to pneumonia virus of mice in C57BL/6 neonates are correlated to reduced protective immunity upon re-infection as elderly mice.
    Shrivastava P; Atanley E; Sarkar I; Watkiss E; Gomis S; van Drunen Littel-van den Hurk S
    Virology; 2015 Nov; 485():233-43. PubMed ID: 26298860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil recruitment and activation are differentially dependent on MyD88/TRIF and MAVS signaling during RSV infection.
    Kirsebom FCM; Kausar F; Nuriev R; Makris S; Johansson C
    Mucosal Immunol; 2019 Sep; 12(5):1244-1255. PubMed ID: 31358860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice.
    Percopo CM; Qiu Z; Phipps S; Foster PS; Domachowske JB; Rosenberg HF
    J Immunol; 2009 Jul; 183(1):604-12. PubMed ID: 19542471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains.
    Anh DB; Faisca P; Desmecht DJ
    Am J Physiol Lung Cell Mol Physiol; 2006 Sep; 291(3):L426-35. PubMed ID: 16556725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory responses to acute pneumovirus infection in neonatal mice.
    Bonville CA; Ptaschinski C; Percopo CM; Rosenberg HF; Domachowske JB
    Virol J; 2010 Nov; 7():320. PubMed ID: 21078159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The caspase inhibitor zVAD increases lung inflammation in pneumovirus infection in mice.
    van den Berg E; Bal SM; Kuipers MT; Matute-Bello G; Lutter R; Bos AP; van Woensel JB; Bem RA
    Physiol Rep; 2015 Mar; 3(3):. PubMed ID: 25780096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
    Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O
    J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
    van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
    J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of T cells in virus control and disease after infection with pneumonia virus of mice.
    Frey S; Krempl CD; Schmitt-Gräff A; Ehl S
    J Virol; 2008 Dec; 82(23):11619-27. PubMed ID: 18815308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unique nonstructural proteins of Pneumonia Virus of Mice (PVM) promote degradation of interferon (IFN) pathway components and IFN-stimulated gene proteins.
    Dhar J; Barik S
    Sci Rep; 2016 Dec; 6():38139. PubMed ID: 27905537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-21 promotes the pathologic immune response to pneumovirus infection.
    Spolski R; Wang L; Wan CK; Bonville CA; Domachowske JB; Kim HP; Yu Z; Leonard WJ
    J Immunol; 2012 Feb; 188(4):1924-32. PubMed ID: 22238461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophils do not impact viral load or the peak of disease severity during RSV infection.
    Kirsebom F; Michalaki C; Agueda-Oyarzabal M; Johansson C
    Sci Rep; 2020 Jan; 10(1):1110. PubMed ID: 31980667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate immune protection from pneumonia virus of mice induced by a novel immunomodulator is prolonged by dual treatment and mediated by macrophages.
    Martinez EC; Garg R; van Drunen Littel-van den Hurk S
    Antiviral Res; 2019 Nov; 171():104594. PubMed ID: 31470041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway.
    Davidson S; Kaiko G; Loh Z; Lalwani A; Zhang V; Spann K; Foo SY; Hansbro N; Uematsu S; Akira S; Matthaei KI; Rosenberg HF; Foster PS; Phipps S
    J Immunol; 2011 May; 186(10):5938-48. PubMed ID: 21482736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy.
    Walsh KB; Teijaro JR; Brock LG; Fremgen DM; Collins PL; Rosen H; Oldstone MB
    J Virol; 2014 Jun; 88(11):6281-93. PubMed ID: 24672024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
    Chávez-Bueno S; Mejías A; Gómez AM; Olsen KD; Ríos AM; Fonseca-Aten M; Ramilo O; Jafri HS
    Virol J; 2005 May; 2():46. PubMed ID: 15916706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.